Skip to content

Improving lives, promoting wellbeing, and delivering sustainable healthcare

Providing high-quality, affordable healthcare solutions, including treatments, devices and services at scale, to achieve profit with purpose.

Non-communicable diseases –
a unique 21st century global health challenge

US$47 trillion
The United Nations has projected that cumulative losses to the global economy due to chronic disease could reach US$47 trillion by 2030.
4 billion
1/2 the world’s population does not have access to the health services it needs.

Each year, 100 million people are pushed into poverty because of out-of-pocket health costs.
100 million
100 million people will die from chronic diseases before they reach 60.

Heart attack and stroke are the world’s leading causes of death.

Driven by a mission to improve the lives of millions of people worldwide

George Health has three businesses, created to commercialise medicines and devices that leverage the George Institute’s late-stage clinical research for chronic disease.



Late-stage drug development of innovative, single-pill combination therapies


Science, service, solutions. A leading CRO in Asia-Pacific with global capabilities

Ellen Medical Devices

The world’s first affordable dialysis system